Breast cancer metastasis to the central nervous system

American Journal of Pathology

Volumn 167, Issue 4, 2005, Pages 913-920

  Weil, Robert J ^a   Palmieri, Diane C ^b   Bronder, Julie L ^b   Stark, Andreas M ^c   Steeg, Patricia S ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PRODRUG; TRASTUZUMAB;

BLOOD BRAIN BARRIER; BRAIN RADIATION; BREAST CANCER; BREAST TUMOR; CELL LINE; CENTRAL NERVOUS SYSTEM METASTASIS; DRUG RESPONSE; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; NEUROIMAGING; ONCOGENE NEU; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; SYMPTOMATOLOGY;

EID: 26244462371     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61180-7     Document Type: Review

References (69)

1. Kleihues P, Cavenee W: Pathology and genetics of tumors of the nervous system. World Health Organization Classification of Tumours. Lyon, IARC Press, 2000
2. Chang E, Lo S: Management of central nervous system metastases from breast cancer. Oncologist 2003, 8:398-410
3. Sawaya R, Bindal R, Lang F, Abi-Said D: Metastatic tumors. Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH, Laws ER, Jr. New York, Churchill Livingston, 2001, pp 999-1026
4. Lassman A, DeAngelis L: Brain metastases. Neurol Clin 2003, 21:1-23
5. Lin N, Bellon J, Winer E: CNS metastases in breast cancer. J Clin Oncol 2004, 22:3608-3617
6. Issa M, Semrau R, Kath R, Hoffken K: Isolated brain metastases as the sole manifestation of a late relapse in breast cancer. J Cancer Res Clin Oncol 2002, 128:61-63
7. Evans A, James J, Cornford E, Chan S, Burrell H, Pinder S, Gutteridge E, Robertson J, Hornbuckle J, Cheung K: Brain metastases from breast cancer: identification of a high-risk group. Clin Oncol 2004, 16:345-349
8. Clark G, Sledge GW Jr, Osborne C, McGuire W: Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987, 5:55-61
9. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
10. Bendell J, Domchek S, Burstein H, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E: Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003, 97:2972-2977
11. Lai R, Dang C, Malkin M, Abrey L: The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 2004, 101:810-816
12. Miller KD, Weathers T, Hanley L, Timmerman R, Dickler M, Shen J, Sledge GW Jr: Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol 2003, 14:1072-1077
13. Kesari S, Batchelor T: Leptomeningeal metastases. Neurol Clin 2003, 21:25-66
14. Gaspar L, Scott C, Rotman M: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 43:745-751
15. Lagerwaard F, Levendag P, Nowak P, Eijkenboom W, Hanssens P, Schmitz P: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803
16. Shaffrey M, Mut M, Asher A, Burri S, Chahlavi A, Chang S, Farace E, Fiveash J, Lang F, Lopes M, Marken J, Schiff D, Siomin V, Tatter S, Vogelcaum M: Brain metastases. Curr Probl Surg 2004, 41:665-741
17. Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M, Werner-Wasik M, Demas W, Ryi J, Bahary J, Souhami L, Rotman M, Mehta Jr M: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672
18. Vecht C, Haaxma-Reiche H, Noordijk E, Padberg G, Voormolen J, Hoekstra F, Tans J, Lambooij N, Metsaars J, Wattendorff A, Brand R, Hermans J: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583-590
19. Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R, Markesbery W, Macdonald J, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500
20. Mintz A, Kestle J, Rathnone M, Gaspar L, Hugenholtz H, Fisher B, Duncan G, Skingley P, Foster G, Levine M: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476
21. Engel J, Eckel R, Aydemir U, Aydemir S, Kerr J, Schlesinger-Raab A, Dirschedl P, Holzel D: Determinants and prognoses of locoregional and distant progression in breast cancer. Int J Radiat Oncol Biol Phys 2003, 55:1186-1195
22. Chambers A, Groom A, MacDonald I: Dissemination and growth of cancer cells in metastatic sites. Nature Cancer Rev 2002, 2:563-572
23. Steeg P: Metastasis suppressors alter the signal transduction of cancer cells. Nature Cancer Rev 2003, 3:55-63
24. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1889, 1:99-101
25. Fidler I: The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nature Rev Cancer 2003, 3:453-458
26. Mundy G: Metastasis to the bone: causes, consequences and therapeutic opportunities. Nature Cancer Rev 2002, 2:584-593
27. Roodman G: Mechanisms of disease. Mechanisms of bone metastasis. N Engl J Med 2004, 350:1655-1664
28. Perou C, Serlie T, Eisen M, Rijn MVD, Jeffrey S, Rees C, Pollack J, Ross D, Johnson H, Akslen L, Fluge O, Pergamenschifkov A, Willams C, Zhu S, Lenning P, Borrensen-Dale A, Brown P, Botstein D: Molecular portraits of human breast tumors. Nature 2000, 406:747-752
29. Weigelt B, Glas A, Wessels L, Witteveen A, Peterse J, Veer LVT: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100:15901-15905
30. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang S-W, Wang H, Wu C, Wang H, Fuller G, Symmans W, Shmulevich I, Zhang W: Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 2004, 100:1110-1122
31. Ramaswamy S, Ross K, Lander E, Golub T: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:1-6
32. Kang Y, Siegel P, Shu W, Drobnjak M, Kakonen S, Cordon-Cardo C, Guise T, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549
33. Zhang R, Fidler I, Price J: Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991, 11:204-215
34. Yoneda T, Williams P, Hiraga T, Niewolna M, Nishimura R: A bone seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001, 16:1486-1495
35. Kim L, Huang S, Lu W, Lev DC, Price J: Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 2004, 21:107-118
36. Micci F, Teixeira M, Heim S: Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH and chromosome-specific painting. Cancer Gen Cytogen 2001, 131:25-30
37. Bergman I, Barmada M, Griffin J, Slamon D: Treatment of meningeal breast cancer xenografts in the rat using an Anti-P185/HER2 antibody. Clin Cancer Res 2001, 7:2050-2056
38. Lee B-C, Lee T-H, Avraham S, Avraham H: Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1a in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004, 2:327-328
39. Lee T, Avraham H, Jiang S, Avraham S: Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J Biol Chem 2003, 278:5277-5284
40. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M: Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 2003, 990:95-112
41. Bart J, Groen H, Hendrikse N, Graff WV, Vaalburg W, deVries E: The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000, 26:449-462
42. Kniesel U, Wolburg H: Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 1997, 20:57-76
43. Lesniak M, Brem H: Targeted therapy for brain tumours. Nature Rev Drug Discov 2004, 3:499-508
44. Sierra A, Price J, Garcia-Ramirez M, Mendez O, Lopez L, Fabra A: Astrocyte derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest 1997, 77:357-368
45. Fontana A, Fierz W, Wekerle H: Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984, 307:273-276
46. Ransom B, Behar T. Nedergaard M: New roles for astrocytes (stars at last). Trends Neurosci 2003, 26:520-522
47. Arnold S, Young A, Munn R, Patchell R, Nanayakkara N, Markesbery W: Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastases. Clin Cancer Res 1999, 5:4028-4033
48. Milas I, Komaki R, Hachiya T, Bubb R, Ro J, Langford L, Sawaya R, Putnam J, Allen P, Cox J, McDonnell T, Brock W, Hong W, Roth J, Milas L: Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res 2003, 9:1070-1076
49. Mehrotra J, Vali M, McVeigh M, Kominsky S, Fackler M, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukamar S: Very high frequency of hypermethylated genes in breast cancer metastasis to bone, brain and lung. Clin Cancer Res 2004, 10:3104-3109
50. Slamon D, Leyland-Jones B, Shak S, Fuchs H, Payton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pagram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against Her2 for metastatic breast cancer that overexpresses Her2. N Engl J Med 2001, 344:783-792
51. Yarden Y, Slikowski M: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001, 2:127-137
52. Clayton A, Danson S, Jolly S, Ryder W, Burt P, Stewart A, Wilkinson P, Welch R, Magee B, Wilson G, Howell A, Wardley A: Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 2004, 91:639-643
53. Yu D, Hung M-C: Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 1991, 6:1991-1996
54. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC: c-erb-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 1994, 54:3260-3266
55. Pestalozzi B, Brignoli S: Traztuzumab in CSF. J Clin Oncol 2000, 18:2350-2351
56. Grossi P, Ochiai H, Archer G, McLendon R, Zalutsky M, Friedman A, Friedman H, Bigner D, Samson J: Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res 2003, 9:1008-1013
57. Monsky W, Carreira CM, Tsuzuki Y, Gohongi T, Fukumura D, Jain R: Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 2002, 8:1008-1013
58. Real P, Sierra A, Juan Ad, Segovia J, Lopez-Vega J, Fernandez-Luna J: Resistance to chemotherapy via StatS-dependent overexpression of Bc1-2 in metastatic breast cancer cells. Oncogene 2002, 21:7611-7618
59. Rubio N, Espna L, Fernandez Y, Blanco J, Sierra A: Metastatic behavior of human breast carcinomas overexpressing the Bcl-xL gene: a role in dormancy and organospecificity. Lab Invest 2001, 81:725-734
60. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan M, McClanahan T, Murphy E, Yuan W, Wagner S, Barrera J, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56
61. Zlotnick A: Chemokines in neoplastic progression. Semin Cancer Biol 2004, 14:181-185
62. Hamasaki H, Aoyagi M, Kasama T, Handa S, Hirakawa K, Taki T: GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside. Biochim Biophys Acta 1999, 1437:93-99
63. Marchetti D, Nicolson G: Human haparanase: a molecular determinant of brain metastasis. Adv Enzyme Regul 2001, 41:343-359
64. Nicolson G, Menter D, Herrmann J, Cavanaugh P, Jia L, Hamada J, Yun Z, Nakajima M, Marchetti D: Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors. Crit Rev Oncog 1994, 5:451-471
65. Toda M, Rabkin S, Martuza R: Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther 1998, 9:2177-2185
66. Price J, Fabra A, Zhang R, Radinsky R, Pathak S: Characterization of variants of a human breast-cancer cell-line isolated from metastases in different organs of nude-mice. Int J Oncol 1994, 5:459-467
67. Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990, 50:717-721
68. Deshmukh P, Glick R, Lichtor T, Moser R, Cohen E: Immunogene therapy with interelukin-2 secreting fibroblasts for intracerebrally metastasizing breast cancer in mice. J Neurosurg 2001, 94:287-292
69. Rye P, Norum L, Olsen D, Vik SG, Kaul S, Fodstad O: Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast cancer cell line, MA11. Int J Cancer 1996, 68:682-687